Immune to Cancer: The CRI Blog
-
Two Immunotherapies Clear Important Regulatory Hurdles
The anti-PD-1 drug nivolumab receives the go-ahead for use in Japan, while in the U.S., CAR-T cells…
-
Making Pancreatic Cancer a Target for Immunotherapy
Researchers show that pancreatic cancer, long known to resist immunotherapy, can be made immunogenic after all.
-
How do you help patients find their hope?
Cynthia, an oncology nurse at Mount Sinai Hospital, has a front row seat for immunotherapy. Hear what…
-
Immunotherapy Today: The View from ASCO
Once again, immunotherapy stole the show at the world’s largest annual cancer meeting.
-
Immunotherapy All the Rage at AACR
Researchers at this year's AACR annual meeting couldn’t stop talking about the promise of immunotherapy.
-
Putting a Hurt on Pancreatic Cancer
CRI postdoc Ingunn Stromnes, PhD, shows that dismantling a tumor’s defense shield makes it vulnerable to immune…
-
Do Bacteria Cause Cancer?
In honor of colorectal cancer awareness month, a look back at our understanding of the role of…
-
Breast Cancer Vaccine Shows Success for Treating Osteosarcoma in Dogs
A cancer immunotherapy originally designed for treating breast cancer in people may also be effective for treating…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.